ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 102 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $3,534,000 | +103.6% | 38,010 | +30.3% | 0.00% | – |
Q3 2021 | $1,736,000 | +20.2% | 29,174 | +37.8% | 0.00% | – |
Q2 2021 | $1,444,000 | -21.5% | 21,169 | -20.1% | 0.00% | -100.0% |
Q1 2021 | $1,839,000 | -2.1% | 26,502 | +8.4% | 0.00% | 0.0% |
Q4 2020 | $1,878,000 | -14.9% | 24,451 | -17.1% | 0.00% | 0.0% |
Q3 2020 | $2,208,000 | +240.7% | 29,507 | +186.4% | 0.00% | – |
Q2 2020 | $648,000 | +66.6% | 10,304 | +11.3% | 0.00% | – |
Q1 2020 | $389,000 | +80.1% | 9,257 | +94.8% | 0.00% | – |
Q4 2019 | $216,000 | +83.1% | 4,753 | +84.0% | 0.00% | – |
Q3 2019 | $118,000 | +24.2% | 2,583 | +59.4% | 0.00% | – |
Q2 2019 | $95,000 | +46.2% | 1,620 | +12.0% | 0.00% | – |
Q1 2019 | $65,000 | -8.5% | 1,447 | -21.0% | 0.00% | – |
Q4 2018 | $71,000 | -53.6% | 1,832 | -45.1% | 0.00% | – |
Q3 2018 | $153,000 | -78.6% | 3,337 | -79.6% | 0.00% | – |
Q2 2018 | $714,000 | +462.2% | 16,383 | +409.3% | 0.00% | – |
Q1 2018 | $127,000 | +4.1% | 3,217 | -10.9% | 0.00% | – |
Q4 2017 | $122,000 | +5.2% | 3,610 | -20.6% | 0.00% | – |
Q3 2017 | $116,000 | +2800.0% | 4,545 | +1965.9% | 0.00% | – |
Q2 2017 | $4,000 | – | 220 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 164,300 | $9,633,000 | 4.86% |
Atika Capital Management LLC | 230,000 | $13,485,000 | 2.65% |
DAFNA Capital Management LLC | 93,942 | $5,508,000 | 2.07% |
PFM Health Sciences, LP | 1,828,378 | $107,198,000 | 2.04% |
Perceptive Advisors | 1,380,171 | $80,919,000 | 1.86% |
Eversept Partners, LP | 73,501 | $4,309,364 | 1.21% |
Partner Investment Management, L.P. | 18,159 | $1,065,000 | 1.13% |
Rhenman & Partners Asset Management AB | 170,000 | $9,967,000 | 1.10% |
EMERALD ADVISERS, LLC | 425,510 | $24,948,000 | 1.00% |
EMERALD MUTUAL FUND ADVISERS TRUST | 388,418 | $22,773,000 | 0.90% |